Kellie Henderson, PA
Medical · Hamilton, TNNPI 1225145865
Payments from drug & device makers
Across 27 payments — averaging $21.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$92
- Lilly USA, LLC$79
- Neurocrine Biosciences, Inc.$51
- Acadia Pharmaceuticals Inc$47
- Astellas Pharma US Inc$42
- Xeris Pharmaceuticals, Inc.$39
- plus $229 from 11 others
What the payments were for
- Food & beverage$578100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 4 | $92 |
| Lilly USA, LLC | 3 | $79 |
| Neurocrine Biosciences, Inc. | 2 | $51 |
| Acadia Pharmaceuticals Inc | 2 | $47 |
| Astellas Pharma US Inc | 2 | $42 |
| Xeris Pharmaceuticals, Inc. | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 1 | $28 |
| Kyowa Kirin, Inc. | 1 | $25 |
| Sunovion Pharmaceuticals Inc. | 1 | $22 |
| Organogenesis Inc. | 1 | $20 |
| Abbott | 1 | $18 |
| Mylan Specialty L.p. | 1 | $17 |
| AstraZeneca | 1 | $17 |
| Avanir Pharmaceuticals, Inc. | 1 | $16 |
| Eisai Inc. | 1 | $15 |
| Novo Nordisk | 1 | $14 |
How this compares
$578 in reported general payments places this provider in the 50th percentile of 480 medical providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lacosamide | 34 | $7,885 |
| EliquisApixaban | 26 | $5,289 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 23 | $1,087 |
| Gabapentin | 83 | $654 |
| Atorvastatin Calcium | 121 | $591 |
| Baclofen | 53 | $466 |
| FenofibrateFenofibrate Nanocrystallized | 53 | $429 |
| ClopidogrelClopidogrel Bisulfate | 83 | $318 |
| Lactulose | 16 | $295 |
| Hydrochlorothiazide | 92 | $292 |
| LoperamideLoperamide Hcl | 41 | $283 |
| Tamsulosin Hcl | 55 | $223 |
| Levothyroxine Sodium | 35 | $207 |
| Furosemide | 58 | $179 |
| Omeprazole | 29 | $174 |
Paid to pharmacies, not to this prescriber.
Other medical in Hamilton
- Maria WoodChattanooga$130K
- Alyssa JamesonFranklin$65K
- Melissa LambertHendersonville$47K
- Stephanie HowardKnoxville$18K
- Evan HatfillNashville$18K
- Meredith McDanielChattanooga$17K
- Janet BreedingKnoxville$15K
- Paul MabenKnoxville$13K
- Hannah KirkGreeneville$13K
- Scarlett FordNashville$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.